Your Dose of Cannabis Education
Your Dose of Cannabis Education
Only have a minute but want to Learn something every day™? Sign up to receive Your Dose of Cannabis Education, bringing featured content from our course library right to your inbox each day.
Your Dose of Cannabis Education is based on data from the studies and reviews published in the current peer-reviewed medical journals. Whether you are a healthcare provider, patient, caregiver, an individual working in the healthcare sector, or just a curious person, you can benefit from Your Dose of Cannabis Education.
Wake up every morning and get your dose of unbiased evidence-based cannabis education!
"Maternal cannabis use during pregnancy is associated with small to moderately increased risks of gestational hypertension, gestational weight gain less than as well as greater than guidelines, and placental abruption. Maternal cannabis use during pregnancy is also associated with small to moderately increased risks of preterm birth, small for gestational age, low birth weight, neonatal intensive care unit admission, and fetal death. The risk of some of these adverse outcomes is greater with greater frequency of cannabis use. These adverse outcomes have been identified even in women who do not use other substances during pregnancy. Other adverse outcomes, such as major congenital malformations and neurodevelopmental disorders, are also reported.""The withdrawal symptoms are non–life-threatening and often include irritability, restlessness, anxiety, sleep disturbances, appetite changes, and abdominal pain. Symptoms usually occur within 3 days after cessation and may last up to 14 days."The American College of Obstetricians and Gynecologists as well as the American Academy of Pediatrics recommend against cannabis use during pregnancy. Yes…"maternal impacts of cannabis use may indirectly impact fetal development via increased carbon monoxide levels, increased uterine artery resistance, placental insufficiency, and decreased expression of placental immune-activating genes.""Endocannabinoid receptors are present in the embryo as early as 5 weeks’ gestation, cannabinoid receptors are involved in early synaptogenesis and neural plasticity, and the fetal neuro- developmental period is vital for long-term neurologic outcomes."
feed…New to TheAnswerPage? There’s lots we’d like to share with you and we don’t want you to miss a thing! Be sure to register today for “Your Dose of Cannabis Education” emails where you’ll gain valuable insights in small doses that fit your schedule and also be provided direct access to the archived daily content.